KITE PHARMA, INC. (KITE) financial statements (2020 and earlier)

Company profile

Business Address 2225 COLORADO AVENUE
SANTA MONICA, CA 90404
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments414615367
Cash and cash equivalents115393209
Short-term investments300222158
Other undisclosed current assets13161
Total current assets:427631368
Noncurrent Assets
Property, plant and equipment44302
Long-term investments and receivables 1 
Long-term investments 1 
Intangible assets, net (including goodwill)3137 
Goodwill2425 
Intangible assets, net (excluding goodwill)711 
Restricted cash and investments11  
Other noncurrent assets1080
Other undisclosed noncurrent assets 1 
Total noncurrent assets:97772
TOTAL ASSETS:524708371
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities40175
Accounts payable1182
Accrued liabilities2920
Employee-related liabilities 72
Due to related parties 00
Deferred revenue and credits1516 
Other undisclosed current liabilities 32
Total current liabilities:55367
Noncurrent Liabilities
Liabilities, other than long-term debt41560
Deferred revenue and credits20320
Other liabilities780
Business combination, contingent consideration, liability1416 
Other undisclosed noncurrent liabilities  1
Total noncurrent liabilities:41561
Total liabilities:96928
Stockholders' equity
Stockholders' equity attributable to parent428616363
Common stock000
Additional paid in capital856776421
Accumulated other comprehensive loss(1)(0)(0)
Accumulated deficit(427)(160)(58)
Total stockholders' equity:428616363
TOTAL LIABILITIES AND EQUITY:524708371

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
Revenues2217 
Cost of revenue
(Cost of Goods and Services Sold)
 (0)(1)
Gross profit:2217(1)
Operating expenses(295)(121)(37)
Other undisclosed operating income 01
Operating loss:(273)(103)(37)
Nonoperating income (expense)32(6)
Investment income, nonoperating420
Other nonoperating income (expense)(0)1(0)
Interest and debt expense(0)(1)(6)
Loss from continuing operations before equity method investments, income taxes:(270)(102)(49)
Other undisclosed income from continuing operations before income taxes0  
Loss from continuing operations before income taxes:(270)(102)(49)
Income tax expense (benefit)3 (12)
Net loss:(267)(102)(60)
Other undisclosed net income attributable to parent 118
Net loss attributable to parent:(267)(102)(43)
Other undisclosed net loss available to common stockholders, basic  (1)
Net loss available to common stockholders, diluted:(267)(102)(44)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
Net loss:(267)(102)(60)
Other undisclosed comprehensive income 118
Comprehensive loss:(267)(102)(43)
Other undisclosed comprehensive loss, net of tax, attributable to parent(1)  
Comprehensive loss, net of tax, attributable to parent:(268)(102)(43)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: